These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 11801566
1. Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant. Duplan SM, Théorêt Y, Kenigsberg RL. Clin Cancer Res; 2002 Jan; 8(1):246-57. PubMed ID: 11801566 [Abstract] [Full Text] [Related]
2. Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1). Kenigsberg RL, Hong Y, Yao H, Lemieux N, Michaud J, Tautu C, Théorêt Y. Am J Pathol; 1997 Sep; 151(3):867-81. PubMed ID: 9284836 [Abstract] [Full Text] [Related]
3. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R. Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398 [Abstract] [Full Text] [Related]
4. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Antoine M, Wirz W, Tag CG, Mavituna M, Emans N, Korff T, Stoldt V, Gressner AM, Kiefer P. Growth Factors; 2005 Jun 15; 23(2):87-95. PubMed ID: 16019430 [Abstract] [Full Text] [Related]
5. Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells. Bangaru ML, Chen S, Woodliff J, Kansra S. Anticancer Res; 2010 Feb 15; 30(2):499-504. PubMed ID: 20332461 [Abstract] [Full Text] [Related]
6. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells. von Bueren AO, Shalaby T, Rajtarova J, Stearns D, Eberhart CG, Helson L, Arcaro A, Grotzer MA. BMC Cancer; 2007 Jan 25; 7():19. PubMed ID: 17254356 [Abstract] [Full Text] [Related]
7. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2. Shain SA. Mol Cancer Res; 2004 Nov 25; 2(11):653-61. PubMed ID: 15561781 [Abstract] [Full Text] [Related]
8. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells. Kim MS, Kim CJ, Jung HS, Seo MR, Juhnn YS, Shin HY, Ahn HS, Thiele CJ, Chi JG. J Pathol; 2004 Jan 25; 202(1):103-12. PubMed ID: 14694527 [Abstract] [Full Text] [Related]
9. Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice. McCall TD, Pedone CA, Fults DW. Cancer Res; 2007 Jun 01; 67(11):5179-85. PubMed ID: 17545597 [Abstract] [Full Text] [Related]
10. The role of fibroblast growth factors and their receptors in prostate cancer. Kwabi-Addo B, Ozen M, Ittmann M. Endocr Relat Cancer; 2004 Dec 01; 11(4):709-24. PubMed ID: 15613447 [Abstract] [Full Text] [Related]
11. Evidence that fibroblast growth factors 1 and 4 participate in regulation of cardiogenesis. Zhu X, Sasse J, McAllister D, Lough J. Dev Dyn; 1996 Dec 01; 207(4):429-38. PubMed ID: 8950517 [Abstract] [Full Text] [Related]
12. FGF-2 inhibits apoptosis in human teratocarcinoma cells during differentiation on collagen substratum. Alanko T, Tienari J, Lehtonen E, Saksela O. Exp Cell Res; 1996 Nov 01; 228(2):306-12. PubMed ID: 8912724 [Abstract] [Full Text] [Related]
13. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma. Schüller U, Schober F, Kretzschmar HA, Herms J. Neuropathol Appl Neurobiol; 2004 Oct 01; 30(5):513-21. PubMed ID: 15488027 [Abstract] [Full Text] [Related]
14. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Fakhry A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, Leboy P, Pacifici M, Kirschner RE, Nah HD. Bone; 2005 Feb 01; 36(2):254-66. PubMed ID: 15780951 [Abstract] [Full Text] [Related]
15. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Taguchi T, Kato Y, Baba Y, Nishimura G, Tanigaki Y, Horiuchi C, Mochimatsu I, Tsukuda M. Oncol Rep; 2004 Feb 01; 11(2):421-6. PubMed ID: 14719078 [Abstract] [Full Text] [Related]
16. Fibroblast growth factor-9 (glia-activating factor) stimulates proliferation and production of glial fibrillary acidic protein in human gliomas either in the presence or in the absence of the endogenous growth factor expression. Miyagi N, Kato S, Terasaki M, Aoki T, Sugita Y, Yamaguchi M, Shigemori M, Morimatsu M. Oncol Rep; 1999 Feb 01; 6(1):87-92. PubMed ID: 9864407 [Abstract] [Full Text] [Related]
17. Region- and stage-specific effects of FGFs and BMPs in chick mandibular morphogenesis. Mina M, Wang YH, Ivanisevic AM, Upholt WB, Rodgers B. Dev Dyn; 2002 Mar 01; 223(3):333-52. PubMed ID: 11891984 [Abstract] [Full Text] [Related]
18. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma. Khnykin D, Troen G, Berner JM, Delabie J. J Pathol; 2006 Feb 01; 208(3):431-8. PubMed ID: 16353171 [Abstract] [Full Text] [Related]
19. Fibroblast growth factors in the nervous system. Eckenstein FP. J Neurobiol; 1994 Nov 01; 25(11):1467-80. PubMed ID: 7852998 [Abstract] [Full Text] [Related]
20. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation. Smits A, van Grieken D, Hartman M, Lendahl U, Funa K, Nistér M. Lab Invest; 1996 Jan 01; 74(1):188-98. PubMed ID: 8569181 [Abstract] [Full Text] [Related] Page: [Next] [New Search]